NasdaqCM:PVLABiotechs
Is Palvella Therapeutics (PVLA) Still Attractive After A 7x One-Year Surge In Price?
If you are wondering whether Palvella Therapeutics at around US$135 is still offering value after a strong run, this article focuses squarely on what the current price might be implying.
The stock has moved sharply recently, with a 57.6% return over the last 7 days, 71.5% over 30 days, and 34.6% year to date, while the 1 year return is very large at close to 7x.
These moves sit against a backdrop of heightened interest in Palvella Therapeutics, including investor attention around its listing...